All In Biotech

Drug Trial Radar · NCT01140126

Study to Evaluate Safety and Pharmacokinetics of UB-421 Antibody in HIV-1 Infected Adults

A Phase I, Open-label, Single-dose, Dose-escalation Study to Evaluate the Safety and Pharmacokinetics of the UB-421 Antibody in Asymptomatic HIV-1 Infected Adults

Last checked: Nov 19, 2026Latest source record: Jul 11, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

20

Actual

Start

May 2010

Primary completion

Jul 2011

Study completion Jul 2011

Sponsor

Lead sponsor
United BiomedicalIndustry
Sponsor type
Industry
First posted
Jun 9, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 20 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this Phase I study is to determine whether the antibody (UB-421), targeting the HIV-1 receptor on the CD4 molecule (domain 1) of T-lymphocytes and monocytes, is safe and well tolerated when administered to asymptomatic HIV-1 infected adults by intravenous infusion and to assess pharmacokinetic parameters of the antibody in blood and on cells. The neutralizing activity of UB-421 blocks HIV-1 from binding to its receptor on CD4-positive cells; thus, UB-421 functions as an immunotherapeutic intervention to prevent HIV-1 infection.

Conditions

  • HIV-1 Infection in Adults (Asymptomatic)

Interventions

  • Antibody UB-421Drug

    Single intravenous infusion at day 0 of a liquid dose of 1, 5, 10 or 25 mg/kg body weight.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To evaluate safety and tolerability of a single intravenous infusion at escalating doses of UB-421.Time frame: Screen, treatment & follow-up: 62 to 90 days

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Taipei Veterans General Hospital (TVGH)

    Taipei, Beitou District, Taiwan

  • Kaohsiung Veterans General Hospital (KVGH)

    Kaohsiung City, Zuoying District, Taiwan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.